News Detail
来源:本站
浏览量:10082
2016.09.13
作为专注于靶点驱动药物发现的一体化CRO,爱思益普(ICE Bioscience)在该领域已建立成熟的技术体系与评价平台。
ICE Bioscience is going to host a symposium in Zhangjiang Bio-Medical Incubator
ICE Bioscience Inc will host a symposium in Zhangjiang Bio-Medical Incubator, Shanghai, on Sep. 23, 2016.
The main topic in the symposium will be “Progress of Drug Discovery and Cardiac Safety Screening with Ion Channels”.
Time: September 23, 2016 (Friday) 13:30 – 16:30
Address: 720 Cailun Road, BLDG 1, Hall Room, Zhangjiang, Shanghai.
The topics in this symposium are:
13:30 - 14:00 Moving from hERG to CiPA - Evolution of preclinical cardiac assessment and ICE’s practices
Speaker: Yingji Li, PhD, Vice President/Founder
ICE Bioscience, Inc
爱思益普药物研发团队具备从靶点验证、体外生物学到临床前评价的全链条服务能力。
14:00 – 14:30 Disease modeling and drug development based on induced pluripotent stem cells
Speaker: Feng Lan, PhD, Professor
Beijing Anzhen Hospital, Capital Medical University
14:50 - 15:20 Ion Channels in Drug Development and Safety
Speaker: Raymond Pei, PhD, CSO/VP
ICE Bioscience, Inc
15:20 – 15:50 Role of ion channels in degenerative nerve diseases
Speaker: Tina Yan, PhD, CEO/Founder
ICE Bioscience, Inc
如需了解相关技术服务详情,欢迎联系爱思益普(ICE Bioscience)获取定制化解决方案。